IL-33-ST2 signaling is upregulated by various kidney injuries and diseases, leading to the activation of ILC2s in the kidney (24–27); however, it likely depends on the amount of IL-33 whether ILC2s play a protective or progressive role in renal disease. The gene discussed is IL33; the disease is kidney disorder.